A. Zanoboni

508 total citations
24 papers, 421 citations indexed

About

A. Zanoboni is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Biochemistry. According to data from OpenAlex, A. Zanoboni has authored 24 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Physiology and 3 papers in Biochemistry. Recurrent topics in A. Zanoboni's work include Growth Hormone and Insulin-like Growth Factors (10 papers), Thyroid Disorders and Treatments (5 papers) and Hormonal Regulation and Hypertension (4 papers). A. Zanoboni is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (10 papers), Thyroid Disorders and Treatments (5 papers) and Hormonal Regulation and Hypertension (4 papers). A. Zanoboni collaborates with scholars based in Italy. A. Zanoboni's co-authors include W. Zanoboni-Muciaccia, C Zanussi, Eugenio E. Müller, Alessandra Forni, F Brambilla, Alessandro Guerrini, Carole Rovère, F. Fraschini, F. Clementi and Frăncesca Brambilla and has published in prestigious journals such as Nature, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

A. Zanoboni

23 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Zanoboni Italy 11 153 147 103 73 47 24 421
M. B. Bender Germany 3 154 1.0× 44 0.3× 185 1.8× 66 0.9× 32 0.7× 4 408
S. Valenti Italy 13 223 1.5× 176 1.2× 115 1.1× 21 0.3× 25 0.5× 42 509
Margaret F. Menadue Australia 12 134 0.9× 147 1.0× 74 0.7× 18 0.2× 112 2.4× 21 466
M Kurcz Hungary 9 65 0.4× 136 0.9× 82 0.8× 57 0.8× 93 2.0× 30 517
Quilianio Contreras Venezuela 12 97 0.6× 82 0.6× 122 1.2× 131 1.8× 92 2.0× 15 380
Angela K. Melson United States 6 257 1.7× 249 1.7× 287 2.8× 340 4.7× 44 0.9× 9 752
E. L. Phelan New Zealand 13 42 0.3× 90 0.6× 159 1.5× 39 0.5× 139 3.0× 28 588
H Beck France 9 382 2.5× 66 0.4× 277 2.7× 22 0.3× 36 0.8× 21 694
Graziano Del Rio Italy 11 88 0.6× 191 1.3× 96 0.9× 33 0.5× 31 0.7× 15 391
Frank Svec United States 9 136 0.9× 137 0.9× 114 1.1× 42 0.6× 27 0.6× 16 377

Countries citing papers authored by A. Zanoboni

Since Specialization
Citations

This map shows the geographic impact of A. Zanoboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Zanoboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Zanoboni more than expected).

Fields of papers citing papers by A. Zanoboni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Zanoboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Zanoboni. The network helps show where A. Zanoboni may publish in the future.

Co-authorship network of co-authors of A. Zanoboni

This figure shows the co-authorship network connecting the top 25 collaborators of A. Zanoboni. A scholar is included among the top collaborators of A. Zanoboni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Zanoboni. A. Zanoboni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brambilla, Frăncesca, E Ferrari, F. Cavagnini, et al.. (1989). α2-Adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or ghrh stimulation. Biological Psychiatry. 25(3). 256–264. 35 indexed citations
2.
Brambilla, Frăncesca, et al.. (1988). Lisuride-induced stimulation of growth hormone release and inhibition of prolactine secretion in heroin-addicted subjects and controls. 10(6). 393–398. 4 indexed citations
3.
Zanoboni, A., et al.. (1988). Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man. Journal of Endocrinological Investigation. 11(6). 413–417. 4 indexed citations
4.
Zanoboni, A., et al.. (1987). Effects of naloxone and coffee on anterior pituitary hormones.. PubMed. 13(7). 443–6. 4 indexed citations
5.
Zanoboni, A., et al.. (1984). INHIBITORY EFFECT OF CIMETIDINE ON L‐DOPA‐STIMULATED GROWTH HORMONE RELEASE IN NORMAL MAN. Clinical Endocrinology. 21(5). 535–540. 5 indexed citations
6.
Zanoboni, A., et al.. (1981). Naloxone and Anterior Pituitary Hormones: Effect on TRH Stimulation Test. Neuroendocrinology. 33(3). 140–143. 10 indexed citations
7.
Zanoboni, A., et al.. (1980). Effects of chronic heroin addiction on pituitary-thyroid function in man. Journal of Endocrinological Investigation. 3(3). 251–255. 15 indexed citations
8.
Zanoboni, A., W. Zanoboni-Muciaccia, & C Zanussi. (1979). Effect of sulpiride and L-dopa on anterior pituitary hormones in plasma of normal men and women.. PubMed. 34(2). 71–84. 1 indexed citations
9.
Zanoboni, A., W. Zanoboni-Muciaccia, & C Zanussi. (1979). ENHANCED TSH STIMULATING EFFECT OF TRH BY SULPIRIDE IN MAN. European Journal of Endocrinology. 91(2). 257–263. 4 indexed citations
10.
Zanoboni, A., et al.. (1979). Suppression of clonidine-induced release of growth hormone by thyrotropin releasing hormone in humans. Journal of Endocrinological Investigation. 2(4). 347–351. 8 indexed citations
11.
Zanoboni, A., Alessandra Forni, W. Zanoboni-Muciaccia, & C Zanussi. (1978). Effect of pinealectomy on arterial blood pressure and food and water intake in the rat. Journal of Endocrinological Investigation. 1(2). 125–130. 60 indexed citations
12.
Zanoboni, A. & W. Zanoboni-Muciaccia. (1977). Elevated Basal Growth Hormone Levels and Growth Hormone Response to TRH in Alcoholic Patients with Cirrhosis. The Journal of Clinical Endocrinology & Metabolism. 45(3). 576–578. 36 indexed citations
13.
Zanoboni, A. & W. Zanoboni-Muciaccia. (1976). ALCOHOL AND CANCER. The Lancet. 307(7974). 1408–1408. 18 indexed citations
14.
Brambilla, F, et al.. (1976). Glucose-insulin metabolism in chronic schizophrenia.. PubMed. 37(2). 98–103. 46 indexed citations
15.
Zanoboni, A., et al.. (1976). Stimulation of insulin secretion in man by oral glycerol administration. Metabolism. 25(1). 41–45. 7 indexed citations
16.
Zanoboni, A. & W. Zanoboni-Muciaccia. (1975). GYNÆCOMASTIA IN ALCOHOLIC CIRRHOSOS. The Lancet. 306(7940). 876–876. 11 indexed citations
17.
Brambilla, F, et al.. (1975). Glucose-insulin metabolism in chronic schizophrenia. Progress in brain research. 42. 373–374. 30 indexed citations
18.
Zanoboni, A. & W. Zanoboni-Muciaccia. (1967). Experimental hypertension in pinealectomized rats. Life Sciences. 6(21). 2327–2331. 70 indexed citations
19.
Clementi, F., F. Fraschini, Eugenio E. Müller, & A. Zanoboni. (1965). The Pineal Gland and the Control of Electrolyte Balance and of Gonadotropic Secretion: Functional and Morphological Observations. Progress in brain research. 585–603. 21 indexed citations
20.
Fraschini, F., Eugenio E. Müller, & A. Zanoboni. (1963). Post-mortem Increase of Potassium in Human Cerebrospinal Fluid. Nature. 198(4886). 1208–1208. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026